← All trials
NCT03580876
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 23, 2018
- Primary completion
- Jun 10, 2019
- Completion date
- Jun 10, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Polyclinique du Parc, 31078 Toulouse, FranceLead sponsor
- Polyclinique du Parc, 31078 Toulouse, FranceReponsible party - principal investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.